KLK-13 antibody inhibitor for treating dry eye
US8821874B2 · kind B2 · utility
0Cited by
21References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2013 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Jul 22, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a method of treating dry eye with a KLK-13 antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.